NCT04788706

Brief Summary

Objectives: To investigate the effect of low-level laser therapy (LLLT) application combined with Russian Electrical Stimulation on pain, mobility, functionality, range of motion, muscular strength, and activity in patients with osteoarthritis of the knee. Design: Randomized controlled double-blind study. Setting: Specialist Rehabilitation Services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
Last Updated

March 9, 2021

Status Verified

December 1, 2020

Enrollment Period

1.9 years

First QC Date

December 29, 2020

Last Update Submit

March 4, 2021

Conditions

Keywords

low level laser therapyRussian electrical stimulation

Outcome Measures

Primary Outcomes (2)

  • Pain intensity

    numeric pain rating scale (0-10) with a minimal clinically important change of two points

    6 months from baseline (follow up)

  • Functionality

    Was measured using the Lequesne questionnaire (11 questions about pain, discomfort and function). Scores range from 0 to 24 (from 'no' to 'extremely severe' dysfunction).

    6 months from baseline (follow up)

Secondary Outcomes (5)

  • Medication intake

    6 months from baseline (follow up)

  • Mobility and balance

    6 months from baseline (follow up)

  • Range of motion of the knees

    6 months from baseline (follow up)

  • Muscular strength

    6 months from baseline (follow up)

  • Activity

    6 months from baseline (follow up)

Study Arms (4)

Group I

ACTIVE COMPARATOR

LLLT over three weeks followed by an eight-week receiving Russian electrical stimulation

Other: Low level Laser Therapy and Russian electrical stimulation

Group II

PLACEBO COMPARATOR

Placebo laser over three weeks followed by an eight-week receiving Russian electrical stimulation

Other: Placebo Laser and Russian electrical stimulation

Group III

ACTIVE COMPARATOR

LLLT over three weeks followed by an eight-week receiving LLLT application combined with Russian electrical stimulation

Other: Low level Laser Therapy and Low level Laser Therapy plus Russian electrical stimulation

Group IV

PLACEBO COMPARATOR

Placebo laser over three weeks followed by an eight-week receiving Placebo laser application combined with Russian electrical stimulation

Other: Placebo Laser and Placebo Laser plus Russian electrical stimulation

Interventions

LLLT over three weeks followed by an eight-week receiving Russian electrical stimulation

Group I

Placebo laser over three weeks followed by an eight-week receiving Russian electrical stimulation

Group II

LLLT over three weeks followed by an eight-week receiving LLLT application combined with Russian electrical stimulation

Group III

Placebo laser over three weeks followed by an eight-week receiving Placebo laser application combined with Russian electrical stimulation

Group IV

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • levels 2-4 according to Kellgren-Lawrence grade
  • aged 50-75 years
  • both genders
  • have knee pain and functional disability for at least three months
  • according to the criteria of the American College for Rheumatology.

You may not qualify if:

  • cancer, diabetes, symptomatic hip osteoarthritis, or used antidepressants, anti-inflammatory medications or anxiolytics during six months prior to enrolment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy, Speech and Occupational Therapy of University of São Paulo

São Paulo, 05360-160, Brazil

Location

MeSH Terms

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • Patricia P Alfredo, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2020

First Posted

March 9, 2021

Study Start

January 1, 2019

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

March 9, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

The results obtained with the study will be made available to participants at the end of the study. These data will be published in articles, so that the anonymity of the participants is guaranteed. All subjects who agreed to participate in the study signed a free and informed consent form and authorized the dissemination of the study results in articles or abstracts presented at scientific congresses.

Locations